BlackRock Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

BlackRock Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7K	Hold	7	–	–	﹤0.01%	3607
2016 Q3	$10K	Sell	7 -2	-22%	-$2.25K	﹤0.01%	3576
2016 Q2	$8K	Buy	9 +2	+29%	+$2.65K	﹤0.01%	3618
2016 Q1	$10K	Hold	7	–	–	﹤0.01%	3578
2015 Q4	$13K	Hold	7	–	–	﹤0.01%	3588
2015 Q3	$14K	Buy	7 +4	+133%	+$9.36K	﹤0.01%	3594
2015 Q2	$7K	Buy	+3	New	+$7.04K	﹤0.01%	3647

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock Advisors's TCON Position: Q4 2016 in Review

BlackRock Advisors held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q4 2016 at 7 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.

BlackRock Advisors first reported a position in TCON in Q2 2015 and has held it in 7 quarters since. The position peaked at $14K in Q3 2015. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2016.

BlackRock Advisors held 7 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $7K as of Q4 2016.
BlackRock Advisors left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2016.
TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3607 holding.
BlackRock Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q3 2015.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.